Clinical Trial

Transcorneal Electrical Stimulation for the Treatment of Visual Field Defects in Patients With Open-Angle Glaucoma

Study acronym: TES-GPS
Recruiting
View on ClinicalTrials.gov →
Summary
Glaucoma is a progressive optic neuropathy with retinal ganglion cell loss which leads to visual field loss. Open-angle glaucoma is the most common form of glaucoma. The aim of this pilot study is to evaluate the safety and effectiveness of the treatment of visual field defects using transcorneal electrical stimulation (TES) with the OkuStim 2 System in patients with primary open-angle glaucoma, pseudoexfoliation glaucoma, pigment dispersion glaucoma or normal tension glaucoma.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-11-08; most recent amendment 2026-03-10.
Status change: Not Yet Recruiting → Recruiting 2025-03-11
Trial Details
NCT Number NCT06682962
Lead Sponsor Okuvision GmbH
Collaborators: Interdisciplinary Center for Clinical Trials, University Medical Center Mainz, University Medical Center of the Johannes Gutenberg University Mainz, Department of Ophthalmology, Sponsored by the German Federal Ministry of Education and Research (FKZ 13GW0732A)
Conditions Glaucoma, Primary Open Angle Glaucoma, Pseudoexfoliation Glaucoma, Pigment Dispersion Glaucoma, Normal Tension Glaucoma
Enrollment 50 participants
Start Date 2025-04-02
Primary Completion 2028-06 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2026-03-12